These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9286178)

  • 21. Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique.
    Sasaki T; Ishiwata K; Murata T; Senda M
    Synapse; 2002 Apr; 44(1):42-50. PubMed ID: 11842445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
    Jensen SB; Olsen AK; Pedersen K; Cumming P
    Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
    Okauchi T; Suhara T; Maeda J; Kawabe K; Obayashi S; Suzuki K
    Synapse; 2001 Aug; 41(2):87-95. PubMed ID: 11400175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic modeling of [11C]raclopride: combined PET-microdialysis studies.
    Endres CJ; Kolachana BS; Saunders RC; Su T; Weinberger D; Breier A; Eckelman WC; Carson RE
    J Cereb Blood Flow Metab; 1997 Sep; 17(9):932-42. PubMed ID: 9307606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cocaine uptake is decreased in the brain of detoxified cocaine abusers.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Hitzemannn R; Gatley SJ; MacGregor RR; Wolf AP
    Neuropsychopharmacology; 1996 Mar; 14(3):159-68. PubMed ID: 8866699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurochemical mechanisms underlying responses to psychostimulants.
    Volkow ND; Fowler JS; Hitzemann R; Wang GJ
    NIDA Res Monogr; 1996; 159():322-48. PubMed ID: 8784863
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of two PET radioligands for imaging extrastriatal dopamine receptors in the human brain.
    Wang GJ; Volkow ND; Fowler JS; Wolf AP; MacGregor RR; Shea CE; Schlyer DJ; Hitzemann RJ
    Synapse; 1993 Nov; 15(3):246-9. PubMed ID: 8278901
    [No Abstract]   [Full Text] [Related]  

  • 28. Gpp(NH)p stimulates [3H]raclopride binding to homogenates from human putamen and accumbens.
    Hall H; Halldin C; Sedvall G
    Neurosci Lett; 1992 Feb; 136(1):79-82. PubMed ID: 1635671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.
    Farde L; Hall H; Ehrin E; Sedvall G
    Science; 1986 Jan; 231(4735):258-61. PubMed ID: 2867601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals.
    Hume SP; Gunn RN; Jones T
    Eur J Nucl Med; 1998 Feb; 25(2):173-6. PubMed ID: 9473266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys.
    Moore RJ; Vinsant SL; Nader MA; Porrino LJ; Friedman DP
    Synapse; 1998 Sep; 30(1):88-96. PubMed ID: 9704885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P; Guan HC; Niznik HB
    Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A PET study with [11-C]raclopride in Parkinson's disease: preliminary results on the effect of amantadine on the dopaminergic system.
    Volonté MA; Moresco RM; Gobbo C; Messa C; Carpinelli A; Rizzo G; Comi G; Fazio F
    Neurol Sci; 2001 Feb; 22(1):107-8. PubMed ID: 11487182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects.
    Smith GS; Schloesser R; Brodie JD; Dewey SL; Logan J; Vitkun SA; Simkowitz P; Hurley A; Cooper T; Volkow ND; Cancro R
    Neuropsychopharmacology; 1998 Jan; 18(1):18-25. PubMed ID: 9408915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic cocaine abuse on postsynaptic dopamine receptors.
    Volkow ND; Fowler JS; Wolf AP; Schlyer D; Shiue CY; Alpert R; Dewey SL; Logan J; Bendriem B; Christman D
    Am J Psychiatry; 1990 Jun; 147(6):719-24. PubMed ID: 2343913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats.
    Ginovart N; Wilson AA; Houle S; Kapur S
    Biol Psychiatry; 2004 Jun; 55(12):1188-94. PubMed ID: 15184038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
    Tateno A; Arakawa R; Okumura M; Fukuta H; Honjo K; Ishihara K; Nakamura H; Kumita S; Okubo Y
    J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Wong DF
    Neuropsychopharmacology; 1992 Aug; 7(1):69-72; discussion 73-5. PubMed ID: 1388023
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of acute metabolic stress on striatal dopamine release in healthy volunteers.
    Adler CM; Elman I; Weisenfeld N; Kestler L; Pickar D; Breier A
    Neuropsychopharmacology; 2000 May; 22(5):545-50. PubMed ID: 10731630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.